Patents by Inventor Jaeduk CHOI

Jaeduk CHOI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11929118
    Abstract: Provided is a non-volatile memory device including a memory cell array including cell strings each including memory cells and a string select transistor connected to a string select line; a page buffer circuit including page buffers each including a forcing latch configured to store forcing information; and a control logic circuit configured to, during a program operation on a selected word line, control at least two of a first voltage applied to the string select line in a first interval before a bit line forcing operation for transferring the forcing information to the selected cell string, a second voltage applied to the string select line in a second interval in which the bit line forcing operation is performed, and a third voltage applied to the string select line in a third interval after the bit line forcing operation is performed, to be different from each other.
    Type: Grant
    Filed: May 19, 2022
    Date of Patent: March 12, 2024
    Assignee: Samsung Electronics Co., Ltd.
    Inventors: Yonghyuk Choi, Yohan Lee, Sangwon Park, Jaeduk Yu
  • Publication number: 20240024426
    Abstract: A method for lowering blood pressure is disclosed. The method includes administering a pharmaceutical composition to a subject in need thereof, wherein the composition contains a pharmaceutically acceptable excipient; and a peptide having an amino acid sequence of any one of SEQ ID NOS: 1 to 102. The peptide is in a form of a long-acting conjugate.
    Type: Application
    Filed: August 17, 2021
    Publication date: January 25, 2024
    Applicant: HANMI PHARM. CO., LTD.
    Inventors: Seungjae BAEK, Jaeduk CHOI, Wonjung SHIN, Jung Kuk KIM, Jong Suk LEE, Jae Hyuk CHOI, Euh Lim OH
  • Publication number: 20230302148
    Abstract: Provided are a pharmaceutical composition including a long-acting conjugate of a triple agonist as an active ingredient and a method of treating obesity and/or a non-alcoholic fatty liver disease using the same. The pharmaceutical composition including the long-acting conjugate of the triple agonist of the present invention may be stably applied to treatment of obesity and/or a non-alcoholic fatty liver disease without side effects according to therapeutic effects on obesity and/or the non-alcoholic fatty liver disease.
    Type: Application
    Filed: August 13, 2021
    Publication date: September 28, 2023
    Applicant: HANMI PHARM. CO., LTD.
    Inventors: Seungjae BAEK, Jaeduk CHOI, Wonjung SHIN, Jung Kuk KIM